Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 548a-2 (MIR548A2) is a human microRNA belonging to the miR-548 family, characterized as a short (20–24 nucleotides) non-coding RNA that exerts regulatory effects by targeting mRNAs for inhibition of translation or destabilization. It is derived from MADE1 transposable elements, a hallmark of primate specificity within the miR-548 family[1][4]. MIR548A2 plays roles in processes such as migration and invasion in cancer cells, and may influence epithelial–mesenchymal transition (EMT) through the regulation of target pathways such as the AHR pathway. Current evidence suggests a role as a tumor suppressor miRNA in breast cancer with the ability to downregulate genes that promote EMT and metastasis[2]. No current evidence suggests therapeutic targeting or interaction with approved drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 548a-2 (MIR548A2).